Health Condition 1: C250- Malignant neoplasm of head of pancreas
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1. Resectable periampullary carcinoma, carcinoma head of pancreas, duodenal adenocarcinoma within 2 cm of ampulla and distal cholangiocarcinoma requiring Pancreatico-duodenectomy 2. Able to provide informed consent 3. ASA I / II patients
Exclusion criteria
Exclusion criteria: 1. Inability to comprehend or follow the PERAS protocol 2. Patients not providing valid informed consent 3. Pregnant patients 4. Patients with psychiatric disorders 5. Unresectable disease 6. ASA more than III
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| To compare the length of stay in hospital, postoperative complications, and readmission rates between patients managed with Prehabilitation augmented ERAS and those receiving traditional ERAS care.Timepoint: At baseline, after 4 weeks and after 8 weeks | — |
Secondary
| Measure | Time frame |
|---|---|
| 1.To assess patient-reported outcomes, such as pain scores, bowel function recovery, quality of life and emotional well-being in the two groups. 2.To evaluate the cost-effectiveness of the Prehabilitation augmented ERAS protocol in comparison to traditional ERAS pathways.Timepoint: At baseline, at 4 weeks & at 8 weeks | — |
Countries
India
Contacts
PGIMER Chandigarh